코오롱제약
1 known investors
Kolon Pharmaceuticals develops pharmaceuticals and runs an oncology drug-discovery platform, using orthotopic transplant animal models and clinical translational research to identify anticancer targets, with a focus on pancreatic and ovarian cancer indications. The South Korean company co-develops new drugs with domestic and international biotech partners.
Investors · 1
Frequently asked questions
- What does 코오롱제약 do?
- Kolon Pharmaceuticals develops pharmaceuticals and runs an oncology drug-discovery platform, using orthotopic transplant animal models and clinical translational research to identify anticancer targets, with a focus on pancreatic and ovarian cancer indications. The South Korean company co-develops new drugs with domestic and international biotech partners.
- Who are 코오롱제약's investors?
- 코오롱제약's investors include Kolon Investment, Inc..